ATE410170T1 - Verwendung von estrogenen zur behandlung von männerunfruchtbarkeit - Google Patents
Verwendung von estrogenen zur behandlung von männerunfruchtbarkeitInfo
- Publication number
- ATE410170T1 ATE410170T1 AT03075894T AT03075894T ATE410170T1 AT E410170 T1 ATE410170 T1 AT E410170T1 AT 03075894 T AT03075894 T AT 03075894T AT 03075894 T AT03075894 T AT 03075894T AT E410170 T1 ATE410170 T1 AT E410170T1
- Authority
- AT
- Austria
- Prior art keywords
- estrogen
- sperm
- drug delivery
- relates
- intranasal
- Prior art date
Links
- 229940011871 estrogen Drugs 0.000 title abstract 4
- 239000000262 estrogen Substances 0.000 title abstract 4
- 208000007466 Male Infertility Diseases 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 3
- 238000012377 drug delivery Methods 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 abstract 2
- 101800000989 Oxytocin Proteins 0.000 abstract 2
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 2
- 230000035558 fertility Effects 0.000 abstract 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 abstract 2
- 229960001723 oxytocin Drugs 0.000 abstract 2
- 230000001850 reproductive effect Effects 0.000 abstract 2
- 210000000582 semen Anatomy 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000019100 sperm motility Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03075894A EP1468690B1 (de) | 2003-03-27 | 2003-03-27 | Verwendung von Estrogenen zur Behandlung von Männerunfruchtbarkeit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE410170T1 true ATE410170T1 (de) | 2008-10-15 |
Family
ID=32892928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03075894T ATE410170T1 (de) | 2003-03-27 | 2003-03-27 | Verwendung von estrogenen zur behandlung von männerunfruchtbarkeit |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1468690B1 (de) |
| AT (1) | ATE410170T1 (de) |
| DE (1) | DE60323938D1 (de) |
| ES (1) | ES2315455T3 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE458491T1 (de) | 2005-08-26 | 2010-03-15 | Univ Leland Stanford Junior | Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin |
| PL3242676T3 (pl) | 2015-01-07 | 2024-07-15 | Tonix Pharma Limited | Preparaty oksytocyny zawierające magnez i sposoby ich stosowania |
| CN109414476B (zh) | 2016-04-12 | 2023-01-31 | 三叉神经股份公司 | 含镁催产素制剂和应用方法 |
| US10709756B2 (en) | 2016-10-26 | 2020-07-14 | Olive Therapeutics, LLC | Treating sexual dysfunction |
| EP3684469A4 (de) * | 2017-09-22 | 2021-06-23 | The University of Adelaide | Verfahren und produkte zur verbesserung der spermaqualität |
| CN110169377B (zh) * | 2019-06-27 | 2021-09-14 | 浙江海洋大学 | 黄姑鱼的人工催产受精方法 |
| CN112999330B (zh) * | 2021-03-18 | 2023-04-18 | 成都大学 | 苯甲酸雌二醇与缩宫素长效混悬注射液的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9701161D0 (sv) * | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use I |
| SE9701162D0 (sv) * | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use II |
| SE9803272D0 (sv) * | 1998-09-25 | 1998-09-25 | Kerstin Uvnaes Moberg | A drug for cell regeneration |
| DE19917930A1 (de) * | 1999-04-15 | 2000-10-19 | Schering Ag | Ent-Steroide als selektiv wirksame Estrogene |
| DK1272504T3 (da) * | 2000-04-12 | 2007-10-01 | Bayer Schering Pharma Ag | 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener |
-
2003
- 2003-03-27 AT AT03075894T patent/ATE410170T1/de not_active IP Right Cessation
- 2003-03-27 EP EP03075894A patent/EP1468690B1/de not_active Expired - Lifetime
- 2003-03-27 DE DE60323938T patent/DE60323938D1/de not_active Expired - Lifetime
- 2003-03-27 ES ES03075894T patent/ES2315455T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1468690A1 (de) | 2004-10-20 |
| EP1468690B1 (de) | 2008-10-08 |
| DE60323938D1 (de) | 2008-11-20 |
| ES2315455T3 (es) | 2009-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Casao et al. | Melatonin prevents capacitation and apoptotic‐like changes of ram spermatozoa and increases fertility rate | |
| AP2001002129A0 (en) | 5HT1 receptor agonists and metoclopramide for the treatment of migrane. | |
| LV11782A (lv) | Lidzeklis no oinicu estrogena atkariga stavokla arstesanai | |
| IL145838A0 (en) | Methods of assessing, improving, urogenital health in postmenopausal women | |
| MA27863A1 (fr) | Forme posologique à libération prolongée d'anesthésiques pour le traitement de la douleur | |
| NZ325060A (en) | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone | |
| ATE410170T1 (de) | Verwendung von estrogenen zur behandlung von männerunfruchtbarkeit | |
| HK1113971A1 (en) | Oral formulations for delivery of catecholic butanes including ndga compounds | |
| Perry et al. | Influence of Sexcel™(gender ablation technology) gender-ablated semen in fixed-time artificial insemination of beef cows and heifers | |
| DE69911023D1 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
| BR0103913A (pt) | Tratamento de combinação para depressão e ansiedade | |
| AU2002311556A1 (en) | Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease | |
| ATE266981T1 (de) | Vorrichtung zur besamung von tieren, insbesondere sauen | |
| DE69912422D1 (de) | Methode zur behandlung von fruchtbarkeitsstörungen | |
| EP1192952A3 (de) | Ein NK-3 rezeptorantagonisten und ein ZNS-penetrierende NK-1 rezeptorantagonisten enthaltende Zusammensetzung zur Behandlung von Depression und Angst | |
| AR043013A1 (es) | Composicion farmaceutica destinada al tratamiento de la endometriosis | |
| HUP0203050A2 (hu) | Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények | |
| ATE491464T1 (de) | Lh zur verwendung der erhaltung einer oder mehreren schwangerschaften durch induktion der bildung des sekundären gelbkörpers. | |
| YU26401A (sh) | Oralni koncentrat sertralina | |
| BR0005319A (pt) | Tratamento combinado para depressão e ansiedade | |
| HUP0302632A2 (hu) | Antigesztagének alkalmazása gyorsított endometriális érés gátlására meddőségi kezelés alatt | |
| EP1260221A3 (de) | Kombinationsbehandlung für Depression und Angstzustände | |
| KR970061245A (ko) | 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물 | |
| AU2001253790A1 (en) | System for measuring an embryo, reproductive organs, and tissue in an animal | |
| ATE361092T1 (de) | Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |